Nanomaterial based Magnetic Resonance Imaging of Cancer

Magnetic Resonance Imaging (MRI) is a widely used non-invasive medical tool for detection and diagnosis of cancer. In recent years, MRI has witnessed significant contributions from nanotechnology to incorporate advanced features such as multimodality of nanoparticles, therapeutic delivery, specific targeting and the optical detectability for molecular imaging. Accurate composition, right scheme of surface chemistry and properly designed structure is essential for achieving desired properties of nanomaterials such as non-fouling surface, high imaging contrast, chemical stability, target specificity and/or multimodality. This review provides an overview of the recent progress in theranostic nanomaterials in imaging and the development of nanomaterial based magnetic resonance imaging of cancer. In particular, targeted theranostics is a promising approach along with its targeting strategy in cancer treatment using MRI and multimodal imaging. We also discuss recent advances in integrin mediated targeted MRI of cancer.

[1]  Wenbin Lin,et al.  Surfactant-assisted synthesis of nanoscale gadolinium metal-organic frameworks for potential multimodal imaging. , 2008, Angewandte Chemie.

[2]  Yongmin Chang,et al.  Paramagnetic nanoparticle T1 and T2 MRI contrast agents. , 2012, Physical chemistry chemical physics : PCCP.

[3]  A. Djamali,et al.  Nephrogenic systemic fibrosis: risk factors and incidence estimation. , 2007, Radiology.

[4]  L. De Cola,et al.  Alkyl-functionalized oxide-free silicon nanoparticles: synthesis and optical properties. , 2008, Small.

[5]  H. Chung,et al.  Nanomaterials for cancer therapy and imaging , 2011, Molecules and cells.

[6]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[7]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[8]  Xiaoyuan Chen,et al.  Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. , 2009, Biomaterials.

[9]  K Kostarelos,et al.  Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. , 2009, Nature nanotechnology.

[10]  A. R. Ramjaun,et al.  The role of cell adhesion pathways in angiogenesis. , 2009, The international journal of biochemistry & cell biology.

[11]  H. Bengele,et al.  A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. , 1990, Magnetic resonance imaging.

[12]  A. P. Hall.  The role of angiogenesis in cancer , 2005, Comparative Clinical Pathology.

[13]  Sophie Lanone,et al.  Potential uses of carbon nanotubes in the medical field: how worried should patients be? , 2007, Nanomedicine.

[14]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[15]  M. Allendorf,et al.  Metal‐Organic Frameworks: A Rapidly Growing Class of Versatile Nanoporous Materials , 2011, Advanced materials.

[16]  É. Boisselier,et al.  Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. , 2010, Chemical reviews.

[17]  Wolfgang J Parak,et al.  Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. , 2010, Pharmacological research.

[18]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[19]  Peter Wipf,et al.  Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.

[20]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[21]  C. Gladson.  Expression of Integrin avß3 in Small Blood Vessels of Glioblastoma Tumors , 1996 .

[22]  Cecilia Sahlgren,et al.  Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. , 2010, Nanoscale.

[23]  Juan Zhao,et al.  Platelet Factor 4 Inhibits IL-17/Stat3 Pathway via Upregulation of SOCS3 Expression in Melanoma , 2014, Inflammation.

[24]  Zhen Guo,et al.  Multifunctional Fe3O4@C@Ag hybrid nanoparticles as dual modal imaging probes and near-infrared light-responsive drug delivery platform. , 2013, Biomaterials.

[25]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[26]  Junichi Takagi,et al.  Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling , 2002, Cell.

[27]  M. Maio,et al.  Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels , 2003, Oncogene.

[28]  P. Gimotty,et al.  Novel surface targets and serum biomarkers from the ovarian cancer vasculature , 2011, Cancer biology & therapy.

[29]  MRI‐Visual Order–Disorder Micellar Nanostructures for Smart Cancer Theranostics , 2014, Advanced healthcare materials.

[30]  F. Vögtle,et al.  Dendrimers and Dendrons: Concepts, Syntheses, Applications , 2001 .

[31]  William C. Zamboni,et al.  Concept and clinical evaluation of carrier-mediated anticancer agents. , 2008, The oncologist.

[32]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[33]  Sungho Jin,et al.  Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. , 2007, Biomaterials.

[34]  Yoon-Sik Lee,et al.  Spontaneous formation of silver nanoparticles on polymeric supports , 2009 .

[35]  M. Ciesielski,et al.  Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[36]  N. M. Rao,et al.  Haloperidol-associated Stealth Liposomes , 2005, Journal of Biological Chemistry.

[37]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[38]  Jinyoung Hwang,et al.  Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging. , 2010, Bioconjugate chemistry.

[39]  Yang Sun,et al.  Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. , 2012, Biomaterials.

[40]  Benjamin R. Jarrett,et al.  Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. , 2008, Bioconjugate chemistry.

[41]  Jun Gao,et al.  PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. , 2013, Biomaterials.

[42]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[43]  K. Geboes,et al.  The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor , 2015, Current eye research.

[44]  Chunhua Yan,et al.  Luminescent rare earth nanomaterials for bioprobe applications. , 2008, Dalton transactions.

[45]  R. Palmer,et al.  Cytotoxicity of the rare earth metals cerium, lanthanum, and neodymium in vitro: comparisons with cadmium in a pulmonary macrophage primary culture system. , 1987, Environmental research.

[46]  D. Gingras,et al.  VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases. , 2007, Thrombosis research.

[47]  Gérard Férey,et al.  Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.

[48]  Zhen Cheng,et al.  Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. , 2010, Small.

[49]  P. Wick,et al.  Carbon nanotubes - curse or blessing. , 2011, Current medicinal chemistry.

[50]  Angelique Y. Louie,et al.  Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. , 2007 .

[51]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[52]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[53]  M. Yeh,et al.  Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery , 2013, International journal of nanomedicine.

[54]  Angelique Louie,et al.  Multimodality imaging probes: design and challenges. , 2010, Chemical reviews.

[55]  Wenbin Lin,et al.  Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. , 2008, Journal of the American Chemical Society.

[56]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[57]  T. Rhim,et al.  Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases , 2004, Angiogenesis.

[58]  J. Muller.  Potential inhibition of the neuro-neoplastic interactions: the clue of a GPCR-targeted therapy. , 2007, Progress in experimental tumor research.

[59]  U. Cavallaro,et al.  The functional role of cell adhesion molecules in tumor angiogenesis. , 2009, Seminars in cancer biology.

[60]  Kai Chen,et al.  PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.

[61]  R. Schiffelers,et al.  RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[62]  Eric C. Carnes,et al.  Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. , 2013, Accounts of chemical research.

[63]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[64]  P. Kolattukudy,et al.  Monocyte Chemotactic Protein (MCP)-1 Promotes Angiogenesis via a Novel Transcription Factor, MCP-1-induced Protein (MCPIP)* , 2008, Journal of Biological Chemistry.

[65]  Qiang Wang,et al.  Polyhydroxy fullerenes for non-invasive cancer imaging and therapy. , 2010, Small.

[66]  Priyabrata Mukherjee,et al.  Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.

[67]  H. Maeda,et al.  Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[68]  M. Poettler,et al.  Tumorangiogenese – Grundlagen und Therapieansätze , 2012 .

[69]  Weibo Cai,et al.  Imaging of integrins as biomarkers for tumor angiogenesis. , 2008, Current pharmaceutical design.

[70]  Yuliang Zhao,et al.  Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs. , 2014, Journal of materials chemistry. B.

[71]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[72]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[73]  Xing-Jie Liang,et al.  Theranostic nanoparticles engineered for clinic and pharmaceutics. , 2011, Accounts of chemical research.

[74]  Xiaohu Gao,et al.  Multifunctional Quantum Dots for Personalized Medicine. , 2009, Nano today.

[75]  T. Yin,et al.  cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. , 2013, Pharmacological research.

[76]  Hong Yang,et al.  Solvothermal synthesis of cobalt ferrite nanoparticles loaded on multiwalled carbon nanotubes for magnetic resonance imaging and drug delivery. , 2011, Acta biomaterialia.

[77]  Dong Wook Kim,et al.  Prostate Cancer-Targeted Imaging Using Magnetofluorescent Polymeric Nanoparticles Functionalized with Bombesin , 2010, Pharmaceutical Research.

[78]  Christopher H Contag,et al.  In vivo pathology: seeing with molecular specificity and cellular resolution in the living body. , 2007, Annual Review of Pathology.

[79]  Thomas Beyer,et al.  PET/CT scanners: a hardware approach to image fusion. , 2003, Seminars in nuclear medicine.

[80]  A. Wanekaya,et al.  Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules. , 2010, Nanotechnology, science and applications.

[81]  C. Mou,et al.  Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. , 2010, Angewandte Chemie.

[82]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[83]  R. Weissleder.  Molecular Imaging in Cancer , 2006, Science.

[84]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[85]  M. Dewhirst,et al.  In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.

[86]  Xiaoyuan Chen,et al.  68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[87]  J. Bulte,et al.  Magnetic resonance imaging of cell surface receptors using targeted contrast agents. , 2004, Current pharmaceutical biotechnology.

[88]  Shuang Liu.  Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging , 2006 .

[89]  Ki Young Choi,et al.  Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. , 2012, Nanoscale.

[90]  S. Caruthers,et al.  Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  L. Claesson‐Welsh,et al.  FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.

[92]  Leone Spiccia,et al.  Nanomaterials: Applications in Cancer Imaging and Therapy , 2011, Advanced materials.

[93]  J. Kos,et al.  Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours , 2005, Expert opinion on biological therapy.

[94]  J. Folkman,et al.  Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.

[95]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[96]  J. Rhim,et al.  Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins , 2004, The Journal of cell biology.

[97]  P. Ang,et al.  Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[98]  Yihai Cao,et al.  PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells , 2011, Nature Medicine.

[99]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[100]  J. Rundhaug,et al.  Matrix metalloproteinases and angiogenesis , 2005, Journal of cellular and molecular medicine.

[101]  Tamitake Itoh,et al.  Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications , 2008, Analytical and bioanalytical chemistry.

[102]  A. Bikfalvi,et al.  Target molecules for anti-angiogenic therapy: from basic research to clinical trials. , 2000, Critical reviews in oncology/hematology.

[103]  A. Blamire,et al.  The technology of MRI--the next 10 years? , 2008, The British journal of radiology.

[104]  J. Brugge,et al.  Src kinase activation by direct interaction with the integrin β cytoplasmic domain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[105]  Mrinmoy De,et al.  Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications. , 2011, Advanced drug delivery reviews.

[106]  Joop A. Peters,et al.  Gadolinium(III)-loaded nanoparticulate zeolites as potential high-field MRI contrast agents: relationship between structure and relaxivity. , 2005, Chemistry.

[107]  Yeup Yoon,et al.  Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site , 2011, Biological chemistry.

[108]  Sang Moo Lim,et al.  RGD Peptide–Conjugated Multimodal NaGdF4:Yb3+/Er3+ Nanophosphors for Upconversion Luminescence, MR, and PET Imaging of Tumor Angiogenesis , 2013, The Journal of Nuclear Medicine.

[109]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[110]  V. Morris,et al.  Differences in phosphatase modulation of α4 β1 and α5 β1 integrin-mediated adhesion and migration of B16F1 cells , 1999 .

[111]  M. Greenblatt,et al.  Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. , 1968, Journal of the National Cancer Institute.

[112]  M. Prato,et al.  Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.

[113]  Akiyoshi Hoshino,et al.  Water-soluble photoluminescent silicon quantum dots. , 2005, Angewandte Chemie.

[114]  Naomi J Halas,et al.  Theranostic nanoshells: from probe design to imaging and treatment of cancer. , 2011, Accounts of chemical research.

[115]  Tingxian Liu,et al.  Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. , 2014, Nanoscale.

[116]  Jodie L. Conyers,et al.  Biomedical applications of functionalized fullerene-based nanomaterials , 2009, International journal of nanomedicine.

[117]  S. Banerjee,et al.  Multifunctional pH-sensitive magnetic nanoparticles for simultaneous imaging, sensing and targeted intracellular anticancer drug delivery , 2008, Nanotechnology.

[118]  Shuming Nie,et al.  Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery , 2006, Molecular Cancer Therapeutics.

[119]  A. Kakkar,et al.  Advances in the elegance of chemistry in designing dendrimers. , 2010, Macromolecular rapid communications.

[120]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[121]  I. Charles,et al.  Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[122]  Yun Sun,et al.  Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. , 2013, ACS nano.

[123]  Younan Xia,et al.  Gold nanostructures: a class of multifunctional materials for biomedical applications. , 2011, Chemical Society reviews.

[124]  Andrew Bulpitt.  Fundamentals of MRI: An Interactive Learning Approach , 2008 .

[125]  Weibo Cai,et al.  Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.

[126]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[127]  T. Irimura,et al.  Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer , 2004, Clinical Cancer Research.

[128]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[129]  Rick M Dijkhuizen,et al.  Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging. , 2012, Neoplasia.

[130]  A. Klibanov,et al.  Drastically lowered protein adsorption on microbicidal hydrophobic/hydrophilic polyelectrolyte multilayers. , 2012, Biomacromolecules.

[131]  B. Garmy-Susini,et al.  Roles of integrins in tumor angiogenesis and lymphangiogenesis. , 2008, Lymphatic research and biology.

[132]  Fiona Murphy,et al.  Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. , 2011, Nanomedicine.

[133]  A. Ivanisevic,et al.  Examining MRI contrast in three-dimensional cell culture phantoms with DNA-templated nanoparticle chains. , 2011, ACS applied materials & interfaces.

[134]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[135]  K. Wu,et al.  Evaluation of the antibacterial efficacy of bamboo charcoal/silver biological protective material , 2009 .

[136]  E Ruoslahti,et al.  RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.

[137]  M. Prato,et al.  Chemistry of carbon nanotubes. , 2006, Chemical reviews.

[138]  M. Brechbiel,et al.  Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiography. , 2012, Molecular pharmaceutics.

[139]  Kwangmeyung Kim,et al.  Engineered protein nanoparticles for in vivo tumor detection. , 2014, Biomaterials.

[140]  M. D. Rowe,et al.  Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer. , 2009, Biomacromolecules.

[141]  Sungho Jin,et al.  Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.

[142]  J. Lilien,et al.  Impaired Integrin-mediated Adhesion and Signaling in Fibroblasts Expressing a Dominant-negative Mutant PTP1B , 1998, The Journal of cell biology.

[143]  M. Prato,et al.  Functionalized carbon nanotubes in drug design and discovery. , 2008, Accounts of chemical research.

[144]  P. Heegaard,et al.  Dendrimers in drug research. , 2004, Chemical Society reviews.

[145]  Kelly Y. Kim,et al.  Nanotechnology platforms and physiological challenges for cancer therapeutics , 2007 .

[146]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[147]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[148]  Enzo Terreno,et al.  Challenges for molecular magnetic resonance imaging. , 2010, Chemical reviews.

[149]  E. Frenkel,et al.  Nanoparticles for drug delivery in cancer treatment. , 2008, Urologic oncology.

[150]  Taeghwan Hyeon,et al.  Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. , 2011, Accounts of chemical research.

[151]  L. Patterson,et al.  Function and antagonism of beta3 integrins in the development of cancer therapy. , 2009, Current cancer drug targets.

[152]  Arthur G Erdman,et al.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[153]  M. Klein,et al.  Virgil Percec and Other Complex Architectures Self-Assembly of Janus Dendrimers into Uniform Dendrimersomes , 2014 .

[154]  Martin W. Brechbiel,et al.  Dendrimer-based macromolecular MRI contrast agents: characteristics and application. , 2003 .

[155]  R. Haag,et al.  Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. , 2002, Angewandte Chemie.

[156]  J. Pollard,et al.  NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. , 2013, Blood.

[157]  P. Choyke,et al.  Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. , 2012, Bioconjugate chemistry.

[158]  Yun Chi,et al.  Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. , 2008, Small.

[159]  Ralph Weissleder,et al.  Sensitive, Noninvasive Detection of Lymph Node Metastases , 2004, PLoS medicine.

[160]  L. True,et al.  Quantum dots for molecular pathology: their time has arrived. , 2007, The Journal of molecular diagnostics : JMD.

[161]  Yan Xing,et al.  Radiolabeled Nanoparticles for Multimodality Tumor Imaging , 2014, Theranostics.

[162]  C. Sorenson,et al.  PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. , 2010, American journal of physiology. Cell physiology.

[163]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[164]  Lanthanide Loaded Zeolites, Clays, and Mesoporous Silica Materials as MRI Probes , 2012 .

[165]  M. D. Rowe,et al.  Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[166]  P. Pantazis,et al.  Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages. , 2010, Journal of the American Chemical Society.

[167]  M. Ballauff,et al.  Dendrimers in solution: insight from theory and simulation. , 2004, Angewandte Chemie.

[168]  D. Cheresh,et al.  An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. , 1995, Journal of cell science.

[169]  G. Tucker.  Integrins: Molecular targets in cancer therapy , 2006, Current oncology reports.

[170]  Scott H. Medina,et al.  Dendrimers as carriers for delivery of chemotherapeutic agents. , 2009, Chemical reviews.

[171]  M. Iruela-Arispe,et al.  ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165* , 2003, Journal of Biological Chemistry.

[172]  J. Minna,et al.  MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. , 2010, Molecular pharmaceutics.

[173]  E. Rozhkova,et al.  Nanoscale Materials for Tackling Brain Cancer: Recent Progress and Outlook , 2011, Advanced materials.

[174]  W. Parak,et al.  Polymeric‐Gold Nanohybrids for Combined Imaging and Cancer Therapy , 2014, Advanced healthcare materials.

[175]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[176]  David A. Benaron,et al.  The Future of Cancer Imaging , 2004, Cancer and Metastasis Reviews.

[177]  P. Alivisatos.  The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[178]  Harish Poptani,et al.  MR techniques for in vivo molecular and cellular imaging. , 2005, Radiologic clinics of North America.

[179]  Hua Ai,et al.  Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.

[180]  Z. Popović,et al.  Amine-terminated silicon nanoparticles: synthesis, optical properties and their use in bioimaging , 2009 .

[181]  A. Paradiso,et al.  Tumor endothelial markers as a target in cancer , 2012, Expert opinion on therapeutic targets.

[182]  L. Schwartz,et al.  Imaging approaches with advanced prostate cancer: techniques and timing. , 2014, The Canadian journal of urology.

[183]  Maureen A Walling,et al.  Quantum Dots for Live Cell and In Vivo Imaging , 2009, International journal of molecular sciences.

[184]  R. Assoian,et al.  Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension. , 2005, Cytokine & growth factor reviews.

[185]  Chungho Kim,et al.  The final steps of integrin activation: the end game , 2010, Nature Reviews Molecular Cell Biology.

[186]  Luisa De Cola,et al.  Photoactive hybrid nanomaterial for targeting, labeling, and killing antibiotic-resistant bacteria. , 2009, Angewandte Chemie.

[187]  Efficient pro-survival/angiogenic miRNA delivery by an MRI-detectable nanomaterial. , 2013, ACS nano.

[188]  Julia Xiaojun Zhao,et al.  Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[189]  Z. Fayad,et al.  Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots , 2008, Angiogenesis.

[190]  Vincent M. Rotello,et al.  Multimodal drug delivery using gold nanoparticles. , 2009, Nanoscale.

[191]  H. Bi,et al.  The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1 , 2014, Molecular vision.

[192]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[193]  Donghoon Lee,et al.  In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.

[194]  Karolin F Meyer,et al.  Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications. , 2008, Bioconjugate chemistry.

[195]  Vincent M Rotello,et al.  Photoregulated release of caged anticancer drugs from gold nanoparticles. , 2009, Journal of the American Chemical Society.

[196]  W. Zamboni.  Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents , 2005, Clinical Cancer Research.

[197]  P. Gullino,et al.  Angiogenesis and oncogenesis. , 1978, Journal of the National Cancer Institute.

[198]  J. Calvete.  Structure-function correlations of snake venom disintegrins. , 2005, Current pharmaceutical design.

[199]  K. Yong.  Mn-doped near-infrared quantum dots as multimodal targeted probes for pancreatic cancer imaging , 2009, Nanotechnology.

[200]  M. Knoth,et al.  Choriocarcinoma. Transfilter stimulation of vasoproliferation in the hamster cheek pouch. Studied by light and electron microscopy. , 1968, Journal of the National Cancer Institute.

[201]  Osamu Togao,et al.  Investigation of In Vivo Targeting Kinetics of αvβ3-Specific Superparamagnetic Nanoprobes by Time-Resolved MRI , 2011, Theranostics.

[202]  Jeffery A. Jones,et al.  Multisensory and modality specific processing of visual speech in different regions of the premotor cortex , 2014, Front. Psychol..

[203]  J. Mathews,et al.  Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians , 2013, BMJ.

[204]  F. Grizzi,et al.  Is angiogenesis a hallmark of prostate cancer? , 2013, Front. Oncol..

[205]  A. Eggermont,et al.  TNF-based isolated limb perfusion: a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas. , 2004, Cancer treatment and research.

[206]  P. Ajayan,et al.  Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation , 2009, Proceedings of the National Academy of Sciences.

[207]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[208]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[209]  C. Anderson,et al.  Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). , 2009, Accounts of chemical research.

[210]  K. Jain.  The role of nanobiotechnology in drug discovery. , 2009, Advances in experimental medicine and biology.

[211]  H. Atreya,et al.  Spontaneous and reversible self-assembly of a polypeptide fragment of insulin-like growth factor binding protein-2 into fluorescent nanotubular structures. , 2010, Chemical communications.

[212]  E. Goldmann.  The Growth of Malignant Disease in Man and the Lower Animals, with special reference to the Vascular System. , 1907, Proceedings of the Royal Society of Medicine.

[213]  M. Reza Mozafari,et al.  Nanomaterials and nanosystems for biomedical applications , 2007 .

[214]  Sharon Bloch,et al.  Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. , 2006, Journal of medicinal chemistry.

[215]  U. Mueller,et al.  Metal–organic frameworks—prospective industrial applications , 2006 .

[216]  F. Auzel.  Upconversion and anti-Stokes processes with f and d ions in solids. , 2004, Chemical reviews.

[217]  Scott C. Brown,et al.  Nanoparticles for bioimaging. , 2006, Advances in colloid and interface science.

[218]  K. Katahira,et al.  Whole-body diffusion-weighted magnetic resonance imaging. , 2009, European journal of radiology.

[219]  Saed Mirzadeh,et al.  The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo. , 2008, Nuclear medicine and biology.

[220]  Hisataka Kobayashi,et al.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. , 2011, Chemical Society reviews.

[221]  Yanqing Hua,et al.  Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. , 2012, Biomaterials.

[222]  Jinming Gao,et al.  In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. , 2009, Cancer research.

[223]  S. Gately,et al.  Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. , 2004, Seminars in oncology.

[224]  Ling Wang,et al.  Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.

[225]  Klaus Kopka,et al.  Encapsulating (111)In in nanocontainers for scintigraphic imaging: synthesis, characterization, and in vivo biodistribution. , 2010, ACS nano.

[226]  R Weissleder,et al.  Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. , 2000, European journal of cancer.

[227]  J. Kong,et al.  Theranostics: MRI-Visualized, Dual-Targeting, Combined Tumor Therapy Using Magnetic Graphene-Based Mesoporous Silica (Small 1/2014) , 2014 .

[228]  J. Bergelson,et al.  Identification of the integrin VLA-2 as a receptor for echovirus 1. , 1992, Science.

[229]  N. Logothetis.  What we can do and what we cannot do with fMRI , 2008, Nature.

[230]  Kyoungjune Pak,et al.  Clinical Implication of PET/MR Imaging in Preoperative Esophageal Cancer Staging: Comparison with PET/CT, Endoscopic Ultrasonography, and CT , 2014, The Journal of Nuclear Medicine.

[231]  H. W. Chalkley,et al.  Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants , 1945 .

[232]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[233]  Mizuo Maeda,et al.  Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. , 2009, Biochemical and biophysical research communications.

[234]  C. ffrench-Constant,et al.  Integrins: versatile integrators of extracellular signals. , 2004, Trends in cell biology.

[235]  J. Willmann,et al.  Molecular ultrasound assessment of tumor angiogenesis , 2010, Angiogenesis.

[236]  Hyo‐suk Lee,et al.  Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model. , 2004, International journal of molecular medicine.

[237]  H. Shan,et al.  An RGD-Modified MRI-Visible Polymeric Vector for Targeted siRNA Delivery to Hepatocellular Carcinoma in Nude Mice , 2013, PloS one.

[238]  C. Marcinkiewicz.  Functional characteristic of snake venom disintegrins: potential therapeutic implication. , 2005, Current pharmaceutical design.

[239]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[240]  Henk-Jan Guchelaar,et al.  Liposomal drug formulations in cancer therapy: 15 years along the road. , 2012, Drug discovery today.

[241]  M. Stevens,et al.  Engineering nanocomposite materials for cancer therapy. , 2010, Small.

[242]  Hyung L. Kim.  Optical imaging in oncology. , 2009, Urologic oncology.

[243]  Yubao Li,et al.  Preparation and antibacterial effect of silver–hydroxyapatite/titania nanocomposite thin film on titanium , 2008 .

[244]  M. D. Rowe,et al.  Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: manipulation of particle size and magnetic resonance imaging capability. , 2011, ACS applied materials & interfaces.

[245]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[246]  O. Boerman,et al.  Radionuclide imaging of tumor angiogenesis. , 2009, Cancer biotherapy & radiopharmaceuticals.

[247]  Zhuo Georgia Chen,et al.  Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.